
Signatur Biosciences
Signatur Biosciences is a YC Summer 2022 (S22) company. Based in London, England, United Kingdom. Team of 5.
About Signatur Biosciences
Summary
Signatur Biosciences builds precision diagnostic kits for complex diseases, starting with breast cancer prognosis. The kits run on standard qPCR machines already in local hospital labs, replacing the need to send samples to specialized central laboratories for analysis on expensive, sophisticated equipment. This cuts turnaround time from several weeks to a few days and reduces cost, bringing molecular diagnostic capability directly to the point of care.
Go-to-market
Customers are hospital labs and the clinicians they serve; adoption is built on compatibility with existing qPCR infrastructure, so labs can integrate the kits without new equipment purchases or workflow overhauls.
From the Y Combinator listing
Simple tests for complex diseases.
We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
Facts
- Healthcare / Healthcare -> Diagnostics
- London, England, United Kingdom
- 5
- Active
- Early
Founders (2)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works